Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Retained Earnings (2024 - 2025)

Carlsmed's Retained Earnings history spans 2 years, with the latest figure at -$100.8 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 41.64% year-over-year to -$100.8 million; the TTM value through Dec 2025 reached -$100.8 million, down 41.64%, while the annual FY2025 figure was -$100.8 million, 41.64% down from the prior year.
  • Retained Earnings reached -$100.8 million in Q4 2025 per CARL's latest filing, down from -$92.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$71.2 million in Q4 2024 to a low of -$100.8 million in Q4 2025.